Part of

  • Download a summary of main clinical outcomes

Jump into the science of Bifidobacterium longum 35624™

Download a summary of main clinical outcomes

  • Bifidobacterium longum 35624™– the power behind the IBme™ technology – is recognized as one of the most effective solutions to ease GI discomfort. ​

  • The efficacy of the strain has been validated by consumers and healthcare professionals and is backed by more than 20 years of research and science, including golden standard clinical trials. ​

Get the summary of main clinical outcomes here

We promise your data will be used only to send you information about Novozymes OneHealth products and services. We don't share contact information with third parties or fill up you inbox with spam.

We'll email the science summary to the address provided.

Fantastic, an email with our main clinical outcomes will be sent shortly to the email address provided. If you do not receive it, please check your junk mail or contact us at novozymesonehealth@novozymes.com

Would you like to connect with us? 

Let us know if you have questions regarding our solutions or if you want to learn more about Rethinking Tomorrow within Human Health.

If you don't hear from us within 48 hours, then we apologize for dropping the ball and would like to know immediately: novozymesonehealth@novozymes.com 

Thanks for getting in contact, one of our team will respond to your query shortly.